Worcester HIV Vaccine is a biotechnology company dedicated to the development of a vaccine to prevent HIV infections around the world. Its polyvalent DNA-prime/protein-boost approach technology developed at the University of Massachusetts Medical School targets multiple subtypes of HIV-1.
OUR CLINICAL TRIAL
People living with HIV
37,900,000
New HIV Infections
1,700,000
per year
HIV-related deaths
770,000
per year
